IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v63y2003i2p215-226.html
   My bibliography  Save this article

Evaluating health interventions: exploiting the potential

Author

Listed:
  • Maynard, Alan
  • McDaid, David

Abstract

No abstract is available for this item.

Suggested Citation

  • Maynard, Alan & McDaid, David, 2003. "Evaluating health interventions: exploiting the potential," Health Policy, Elsevier, vol. 63(2), pages 215-226, February.
    • Handle: RePEc:eee:hepoli:v:63:y:2003:i:2:p:215-226
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(02)00068-4
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Landry, Rejean & Amara, Nabil, 1998. "The impact of transaction costs on the institutional structuration of collaborative academic research," Research Policy, Elsevier, vol. 27(9), pages 901-913, December.
    2. Alan Williams, 2001. "Science or marketing at who? Rejoinder from Alan Williams," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 283-285, June.
    3. Nick Freemantle & Alan Maynard, 1994. "Something rotten in the state of clinical and economic evaluations?," Health Economics, John Wiley & Sons, Ltd., vol. 3(2), pages 63-67, March.
    4. Reinhardt, Uwe E., 1997. "Making economic evaluations respectable," Social Science & Medicine, Elsevier, vol. 45(4), pages 555-562, August.
    5. Evans, R.G. & Barer, M. & Morgan, S., 2000. "Health Economists Meet the Fourth Tempter: Drog Dependency and Scientific Discourse," Centre for Health Services and Policy Research 2000:16r, University of British Columbia - Centre for Health Services and Policy Research..
    6. Alan Maynard, 1997. "Economic Evaluation Techniques in Healthcare," PharmacoEconomics, Springer, vol. 11(2), pages 115-118, February.
    7. Baker, Laurence C., 2001. "Managed care and technology adoption in health care: evidence from magnetic resonance imaging," Journal of Health Economics, Elsevier, vol. 20(3), pages 395-421, May.
    8. Steve Morgan & Morris Barer & Robert Evans, 2000. "Health economists meet the fourth tempter: drug dependency and scientific discourse," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 659-667, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. McMahon, Meghan & Morgan, Steve & Mitton, Craig, 2006. "The Common Drug Review: A NICE start for Canada?," Health Policy, Elsevier, vol. 77(3), pages 339-351, August.
    2. Dimitrios Rovithis & Lycurgus Liaropoulos, 2008. "The CHESME Health Economic Evaluations Database (CHESME HEED) project," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(2), pages 99-101, May.
    3. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
    4. Wolfgang Greiner, 2005. "Health economic evaluation of disease management programs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 191-196, September.
    5. Maria Gabriella Melchiorre & Giovanni Lamura & Francesco Barbabella & on behalf of ICARE4EU Consortium, 2018. "eHealth for people with multimorbidity: Results from the ICARE4EU project and insights from the “10 e’s” by Gunther Eysenbach," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-26, November.
    6. Laurent Molinier & Hélène Bocquet & Vanina Bongard & Bernard Fraysse, 2009. "The economics of cochlear implant management in France: a multicentre analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 347-355, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Vuorenkoski, Lauri & Toiviainen, Hanna & Hemminki, Elina, 2003. "Drug reimbursement in Finland--a case of explicit prioritising in special categories," Health Policy, Elsevier, vol. 66(2), pages 169-177, November.
    2. McMahon, Meghan & Morgan, Steve & Mitton, Craig, 2006. "The Common Drug Review: A NICE start for Canada?," Health Policy, Elsevier, vol. 77(3), pages 339-351, August.
    3. Steve Morgan & Morris Barer & Robert Evans, 2000. "Health economists meet the fourth tempter: drug dependency and scientific discourse," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 659-667, December.
    4. Paul Grootendorst, 2009. "Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation?," Social and Economic Dimensions of an Aging Population Research Papers 250, McMaster University.
    5. Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs, 2015. "How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 273-279, June.
    6. Clive Pritchard, 1998. "Trends in Economic Evaluation," Briefing 000444, Office of Health Economics.
    7. Daron Acemoglu & Amy Finkelstein, 2008. "Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector," Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
    8. Manning, Stephan, 2017. "The rise of project network organizations: Building core teams and flexible partner pools for interorganizational projects," Research Policy, Elsevier, vol. 46(8), pages 1399-1415.
    9. Maynou, L. & McGuire, A. & Serra-Sastre, V., 2019. "Exploring the Impact of New Medical Technology on Workforce Planning," Working Papers 19/07, Department of Economics, City University London.
    10. Joon Mahn Lee & Rahul Kapoor, 2017. "Complementarities and Coordination: Implications for Governance Mode and Performance of Multiproduct Firms," Organization Science, INFORMS, vol. 28(5), pages 931-946, October.
    11. Defazio, Daniela & Lockett, Andy & Wright, Mike, 2009. "Funding incentives, collaborative dynamics and scientific productivity: Evidence from the EU framework program," Research Policy, Elsevier, vol. 38(2), pages 293-305, March.
    12. Laurence Baker & Joanne Spetz, 1999. "Managed Care and Medical Technology Growth," NBER Chapters, in: Frontiers in Health Policy Research, volume 2, pages 27-52, National Bureau of Economic Research, Inc.
    13. David Kernick, 2002. "Health economics: an evolving paradigm but sailing in the wrong direction? A view from the front line," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 87-88, January.
    14. Barry Bozeman & Monica Gaughan & Jan Youtie & Catherine P. Slade & Heather Rimes, 2016. "Research collaboration experiences, good and bad: Dispatches from the front lines," Science and Public Policy, Oxford University Press, vol. 43(2), pages 226-244.
    15. Karine Lamiraud & Stephane Lhuillery, 2016. "Endogenous Technology Adoption and Medical Costs," Health Economics, John Wiley & Sons, Ltd., vol. 25(9), pages 1123-1147, September.
    16. Diego Ubfal & Alessandro Maffioli, 2010. "The Impact of Funding on Research Collaboration: Evidence from Argentina," SPD Working Papers 1006, Inter-American Development Bank, Office of Strategic Planning and Development Effectiveness (SPD).
    17. Danilo Silva Carvalho & Lucas Lopes Felipe & Priscila Costa Albuquerque & Fabio Zicker & Bruna de Paula Fonseca, 2023. "Leadership and international collaboration on COVID-19 research: reducing the North–South divide?," Scientometrics, Springer;Akadémiai Kiadó, vol. 128(8), pages 4689-4705, August.
    18. Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015. "Public health insurance expansions and hospital technology adoption," Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
    19. Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo, 2013. "Income and Health Spending: Evidence from Oil Price Shocks," The Review of Economics and Statistics, MIT Press, vol. 95(4), pages 1079-1095, October.
    20. Damian Walker & Julia A. Fox‐Rushby, 2000. "Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 681-698, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:63:y:2003:i:2:p:215-226. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.